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Abstract  
The inhibition of marine biofouling by the bromotyrosine derivative ianthelline, isolated from the Arctic 
marine sponge Stryphnus fortis, is described. All major stages of the fouling process are investigated. The 
effect of ianthelline on adhesion and growth of marine bacteria and microalgae is tested to investigate its 
influence on the initial microfouling process comparing with the known marine antifoulant barettin as a 
reference. Macrofouling is studied via barnacle (Balanus improvisus) settlement assays and blue mussel 
(Mytilus edulis) phenoloxidase inhibition. Ianthelline is shown to inhibit both marine micro- and macrofoulers 
with a pronounced effect on marine bacteria (minimum inhibitory concentration (MIC) values 0.1–10 μg/mL) 
and barnacle larval settlement (IC50=3.0 μg/mL). Moderate effects are recorded on M. edulis (IC50=45.2 μg/mL) 
and microalgae, where growth is more affected than surface adhesion. The effect of ianthelline is also 
investigated against human pathogenic bacteria. Ianthelline displayed low micromolar MIC values against 
several bacterial strains, both Gram positive and Gram negative, down to 2.5 μg/mL. In summary, the effect of 
ianthelline on 20 different representative marine antifouling organisms and seven human pathogenic 
bacterial strains is presented. 
 
Introduction 
Rapid colonisation and successive overgrowth of epibiotic organisms on a surface immersed in water is a 
process known as biofouling. It is a fast and complex sequence of events which is initiated by surface adhesion 
of organic molecules, followed by the rapid settlement of microfoulers (marine bacteria, protozoans and 
microalgae) and, subsequently, macrofoulers (macroalgae and invertebrates) (Qian et al. 2007; Yebra et al. 
2004). Biofouling is a natural process, yet it is highly undesired for a wide range of marine economic sectors 
such as shipping, aquaculture and the offshore petroleum industry. The growth on associated man-made 
structures leads to substantial economic losses in these sectors mainly due to increased fuel usage, 
maintenance costs and process parameter interference (Yebra et al. 2004; Fitridge et al. 2012). Employment 
of antifouling (AF) paints has been the most successful strategy to prevent biofouling on such structures 
(Almeida et al. 2007). The most efficient AF compounds such as organotin and copper oxide have been shown 
to come with several serious environmental drawbacks (Okoro et al. 2011; Kotake 2012; Nakanishi 2008) due 
to the collateral damage inflicted on the marine environment and non-target species. The high toxicity and 
induction of imposex, i.e. the development of male characteristics by females, amongst marine molluscs (Ellis 
and Pattisina 1990; Nakanishi 2008) resulted in a total ban on the use of organotin-based compounds in the 
marine environment which was implemented in 2008. 
 Not only man-made structures submerged in water but also sessile marine organisms such as sponges and 
tunicates serve as surfaces for biofouling and are under a constant threat of being overgrown by epibionts. 
Despite this, many sessile marine organisms appear to have developed strategies to combat epibiosis and 
maintain a clean exterior surface, free of settling species (Muller et al. 2013). This observation has motivated 
the search formarine compounds with AF activities from their arsenal of secondary metabolites (Tsukamoto et 
al. 1996a; Fusetani 2004, 2011; Hellio et al. 2005). Marine sponges in particular are a rich source of bioactive 
secondary metabolites, some with documented AF activity (Sipkema et al. 2005; Stowe et al. 2011; Gerwick 
and Moore 2012). Sponges are primitive sessile filter-feeders that lack a specialised immune system and the 
ability to remove themselves from predators and settling organisms. To prevail, they have developed physical 
and chemical defence strategies to protect themselves against over-growth by epibionts (Muller et al. 2013). 
Sponges commonly host a range of microbial symbionts that may produce compounds protecting their host. 
Sponges therefore represent a particularly rich marine source for discovering novel compounds (Gerwick and 
Fenner 2013; Gerwick and Moore 2012; Ortlepp et al. 2007). 
 
One group of marine compounds described in the literature that display particular potential as antifoulants 
are bromotyrosine-derived sponge metabolites (Ortlepp et al. 2007). Several such compounds have been 
studied, and their inhibition of balanide larval settlement has been described (Ortlepp et al. 2007). Similar 
brominated marine compounds such as barettin and oroidin (Fig. 1) have also been extensively investigated as 
potential leads for additives in marine paints as “green” settlement deterrents (Sjogren et al. 2004b; Yamada 
et al. 1997). Both barretin and oroidon and their synthetic derivatives have been incorporated in paint 
formulations and shown to prevent biofouling in field studies (Melander et al. 2009; Sjogren et al. 2004a). 
Synthetic analogues of bromotyrosines isolated from sponges have further been shown to inhibit 
phenoloxidase frombluemussels at low micromolar concentrations (Bayer et al. 2011). 
 
Following on the ban on organotin compounds, marine natural products have received an increased focus and 
have even been heralded as the way forward towards environmentally friendly AF solutions (Bhadury and 
Wright 2004; Marechal and Hellio 2009; Qian et al. 2010; de Nys and Steinberg 2002). Searches for such 
compounds within the phylum Porifera are ongoing and provide sound basis that an environmentally friendly 
compound may be isolated from marine sponges (Tsukamoto et al. 1996a; Santos Acevedo et al. 2013). Being 
of natural origin does not guarantee that the marine AF compounds are non-toxic, but they come with the 
advantage of having been tuned by evolution for their task. The ideal “green” AF compound should be 
deterring rather than toxic to the target species (Dobretsov et al. 2006; Marechal and Hellio 2009; Chambers 
et al. 2006). 
 
In this study, we report the AF activities of ianthelline (1) (displayed in Fig. 1 together with structurally related 
marine AF compounds), a bromotyrosine derivative isolated from the Arctic sponge Stryphnus fortis (Hanssen 
et al. 2012). The structure of 1 was determined in 1986 (Litaudon and Guyot 1986), and its synthesis was 
recently described by Shearman et al. (2010). 
 
Fig. 1 Structure of ianthelline (1) and structurally and marinerelated compounds that have been evaluated as 
AF compounds: 5,5’-dibromohemibastadin-1 (2), barettin (3) and oroidin (4) 
 
Compound 1 was originally isolated from the Caribbean sponge Ianthella ardis and has been shown to be a 
major secondary metabolite in several other warm water sponges (Litaudon and Guyot 1986; Ciminiello et al. 
1995). It is a bioactive compound, and the antitumoral activity of 1 was published in 2012 by Hanssen et al. 
(2012). The initial isolation paper briefly reported antibacterial and antifungal bioactivities against one 
bacterial and one fungal strain (Litaudon and Guyot 1986). Apart from those studies, little is known about the 
potential bioactivities of 1, and its ecological role is not understood. A fractionated extract from the Caribbean 
sponge Aiolochroia crassa containing 1 has been reported to inhibit the attachment of marine bacteria to agar 
blocks (Kelly et al. 2003, 2005). The pooled fractionated extracts prepared in that particular study was studied 
at natural volumetric concentrations. Thus, the amount, purity, and bioactive concentration of 1 were 
unknown. The attachment inhibition of Vibrio harveyi was examined, and growth values ranging from 14 to 61 
%, compared to growth control, in five different fractions rich in 1 was reported (Kelly et al. 2005). 
 
The optimisation of synthetic bromotyrosine derivatives for phenoloxidase inhibition revealed a 
pharmacophore that is highly analogous to the substructures displayed by 1, suggesting additional 
bioactivities for 1 (Bayer et al. 2011). Compound 1 contains an oxime moiety, postulated by Proksch and 
coworkers, to be essential for AF activity, and it represents an interesting compound for further studies 
towards AF solutions (Ortlepp et al. 2007). 
 
The present study is thus an important continuation of the previously limited studies of the bioactivity and 
potential ecological role of 1 and also represents an assessment of the exploitability of 1 for biotechnological 
and medical purposes. Herein, we describe how 1 is isolated from an Arctic source and tested in a wide array 
of assays (Svenson 2013). In the marine environment, biofouling is undertaken by a great diversity of species, 
and marine AF compounds should therefore ideally possess a broad-spectrum activity to contend with the 
vast amount of epibionts. The effect of 1 on the growth and settlement inhibition of ten marine bacterial and 
eight microalgal strains relevant to the formation of the biofouling film as well as studies on Balanus 
improvisus barnacle larvae settlement inhibition is described. A potential effect on bivalves is also studied 
using the Mytilus edulis phenoloxidase assay. Finally, the effect of 1 on a test panel of seven human 
pathogenic bacterial strains is investigated to evaluate the inhibitory effect on medically important strains. 
Comparisons with relevant structurally related, marine secondary metabolites are included and discussed. 
 
Materials and Methods 
 
Organism and Purification of 1 and 3 
 
The specimen of S. fortis was collected off the coast of Spitsbergen (79° 33’ N, 8° 53’ E) in September 2007. 
Extraction, purification and structure determination of 1 was carried out as previously described (Hanssen et 
al. 2012).  
 
For comparison, 3 was isolated from Geodia barretti, collected off the coast of Tromsø, Norway, in 2009. The 
compound was extracted according to previous methods and purified from a desalted 40 % RP-SPE extract 
(Tadesse et al. 2008) using a Waters SunFire Prep C18 HPLC column (10×250 mm, 5 μm particle size). A linear 
gradient from 15 to 30% acetonitrile in ultra-pure water containing 0.1 % TFA (v/v) was applied at 4 mL/min 
over 50 min to elute 3. The compound was identified by high-resolution mass spectrometry (HR-MS and HR-
MS/MS) using a LTQ Orbitrap XL Hybrid Fourier Transform mass spectrometer (Thermo Fischer Scientific, MA, 
USA) and by comparison with previously published data on 3 (Lidgren and Bohlin 1986; Solter et al. 2002). 
 
Marine Antibacterial Assays 
 
Tenmarine bacterial strains from the bacterial collection of the University of Portsmouth School of Biological 
Sciences were used in the current study (Table 1).  
 
Table 1  Marine bacterial strains used in the present study 
Marine bacteria  ATCC1 
Halomonas aquamarina  14400 
Polaribacter irgensii  700398 
Pseudoalteromonas elyakovii  700519 
Roseobacter litoralis  49566 
Shewanella putrefaciens  8071 
Vibrio aestuarianus  35048 
Vibrio carchariae  35084 
Vibrio harveyi  700106 
Vibrio natriegens  14058 
Vibrio proteolyticus  53559 
1American tissue culture code 
These selected strains are representative of fouling species in both estuarine and marine environments 
(Chambers et al. 2011). They were grown at 26 °C in a marine medium, composed of 0.5 % peptone 
(neutralised bacteriological peptone, Oxoid LTD) in filtered (Whatman 1,001-270, pore size 11 μm) natural 
seawater from the Solent (UK). Compounds 1 and 3 were dissolved in 100 % methanol (general purpose 
grade, Fisher Chemical) and transferred to clear polystyrene 96-well plates (Fisher Scientific), dried under 
vacuum and sterilised under UV illumination. Wells were prepared using concentrations of 0.01, 0.1, 1 and 10 
μg/mL, and each concentration was replicated six times (Bressy et al. 2010). Both growth and adhesion 
inhibition were studied. 
 
– Growth inhibition experiments 
One hundred microlitres of bacterial culture (2×108 colony forming units (CFU) mL−1) was added to each well 
under aseptic conditions and incubated for 48 h at 26 °C. The minimum inhibitory concentration (MIC) was 
defined as the minimum concentration resulting in no change in optical density at 630 nm after incubation for 
48 h (Thabard et al. 2011). 
 
– Adhesion inhibition experiments 
Microplates were prepared and inoculated as stated above. After a 48-h incubation, wells were emptied and 
rinsed once with 100 μL of sterile seawater to remove the non-attached cells and air-dried at room 
temperature. The remaining bacterial biofilm was stained with 100 μL of 0.3 % (v/v) aqueous crystal violet, 
and the optical density (OD) was measured at 595 nm (Sonak and Bhosle 1995). 
 
Media was used as blank, and MIC was defined as the lowest concentration that produced a reduction in 
adhesion. 
 
Microalgal Assay 
 
Eight pure, but non-axenic, marine microalgae (obtained from Algobank, Caen, France) were used in this study 
(Table 2).  
 
Table 2 Microalgae used in the present study 
Microalgae  Algobank code 
Cylindrotheca closterium  AC 170 
Exanthemachrysis gayraliae  AC 15 
Halamphora coffeaeformis  AC 713 
Pleurochrysis roscoffensis  AC 32 
Porphyridium purpureum  AC 122 
Hymenomonas coronata  AC 115 
Rhodosorus marinus  AC 119 
Pleurochrysis carterae  AC 1 
 
 
All the included strains are involved in surface colonisation and can lead to increased rates of biocorrosion 
(Jellali et al. 2013). Each algal strain was grown for 5 days prior to use at 20 °C in F/2 medium. After 5 days, 
microalgal concentration was assessed via analysis of the chlorophyll a content (Chambers et al. 2011), and 
dilutions of the stock culture were made accordingly to generate stock solutions of each microalgae 
containing 0.1 mg/L chlorophyll a. One hundred microlitres of the stock solutions were transferred to the 
wells of black 96-well plates prepared with ranging concentrations of 1 and 3 as described above. Both 
adhesion and growth inhibition were studied. 
 
– Growth inhibition experiments 
The inoculated plates were grown for 5 days under constant light exposure (140 μmol m−2 s−1) at 20 °C. 
After the incubation, the microplates were centrifuged at 4,100 rpm for 10 min at 4 °C using a Beckman 
Coulter Allegra 25R centrifuge and subsequently emptied. One hundred microlitres of 100% methanol was 
added to each well to liberate chlorophyll a. The pigment concentration was quantified employing the 
fluorimetric method (Chambers et al. 2011). MIC values were calculated as explained for bacteria (based on 
OD measurements). 
 
– Adhesion inhibition experiments 
Black microplates were prepared and inoculated as stated above. Media was used as blank. After 5 days of 
incubation, the medium was gently removed using a multichannel pipette to eliminate all the non-attached 
cells. One hundred microlitres of 100 % methanol was then added to each well to liberate chlorophyll a. The 
pigment concentration was quantified employing the fluorimetric method explained above. 
 
Balanus Cyprid Settlement  
 
Cyprid larvae of B. improvisus were reared in a laboratory cultivating system at Tjärnö Marine Biological 
Laboratory, as described by Berntsson et al. (2000). The settlement assays with B. improvisus cyprids were 
conducted in non-treated polystyrene Petri dishes (Ø 48mm, Nunc #150340) containing 10 mL filtered (0.2 
μm) seawater. Compound 1 was dissolved in DMSO and then serially diluted with DMSO to give the desired 
concentration series of which 10 μL was added to each test dish. A total of 18–22 newly moulted cyprids were 
added to each test dish which were incubated at room temperature (20–25 °C) for 5 days. At the end of the 
experiment, the number of metamorphosed juvenile barnacles, as well as live and dead cyprids, was assessed 
under a dissectionmicroscope. Each concentration of 1 was replicated four times (n=4), and dishes with 10 μL 
DMSO served as controls. The concentration of 1 leading to 50%inhibition of the settlement compared to the 
control was reported as the IC50 value. 
 
  
Inhibition of Phenoloxidase from the Blue Mussel M. edulis 
 
Phenoloxidase was isolated from the byssus gland of the blue mussel (M. edulis) as previously described 
(Hellio et al. 2000; Bayer et al. 2011). Solutions of 1 mg/mL M. edulis phenoloxidase, 0.4 mM  
L-dihydroxyphenylalanine (DOPA), and 1 (2–2,000 μg/mL) were prepared. One millilitre of the LDOPA solution, 
10 μL 1 (or 10 μL of water in the case of the control samples), and 10 μL M. edulis phenoloxidase (added last) 
were mixed in a test tube. Phosphate buffered saline (pH 6.8) was added to the solution tomake a total 
volume of 2 mL. The solution was placed in a cuvette, and the change in absorbance at 475 nm was measured 
after 30 min using a UV-VIS spectrophotometer. The blank control used was the sample without the enzyme 
solution. The assay was run in triplicate, and the concentration of 1 leading to 50% inhibition of the 
phenoloxidase activity result was reported as the IC50 value. 
 
Terrestrial Antibacterial Assay 
 
The MIC of 1 was determined against seven human pathogenic bacterial strains presented in Table 3. 
 
Table 3 Human pathogenic bacterial strains used in the current study 
Bacterial strain  ATCC 
Gram positive 
Staphylococcus aureus  25923 
MRSA  33591 
Staphylococcus epidermidis  35984 
Streptococcus agalactiae  12386 
Enterococcus faecalis  29212 
Gram negative 
Escherichia coli  25922 
Pseudomonas aeruginosa  27853 
 
Enterococcus faecalis and Streptococcus agalactiae were grown in brain-heart infusion broth (BHI; Oxoid, 
Hampshire, England). Staphylococcus aureus, methicillin-resistant S. aureus (MRSA), Escherichia coli and 
Pseudomonas aeruginosa were grown in Mueller Hinton Broth (MH; Merck, Darmstadt, Germany), and 
Staphylococcus epidermidis in tryptic soy broth (TS; Merck, Darmstadt, Germany). Both growth and biofilm 
inhibition studies were performed. 
 
– Growth inhibition experiments 
Suspended bacteria in log phase grown at 37 °C in growth medium were added to 96-well microtiter plates 
resulting in 1,500–15,000 CFU/mL. A serial dilution of 1 was subsequently added and left to inoculate for 24 h 
before growth inhibition was observed with a Victor multilabel counter at 600 nm. Growth medium diluted 
with water (1:1) was used as negative control, and bacteria suspension diluted with water (1:1) was used as 
positive control. Gentamicin at ranging concentrations from 0.015 to 16 μg/mL was used as positive assay 
control. The MIC was defined as the minimum concentration resulting in no change in optical density after 
incubation for 24 h at 37 °C. Compound 1 was tested at concentrations ranging from 2.5 to 160 μg/mL. 
 
– Inhibition of biofilm formation 
S. epidermidis was used to assess the effect of 1 on biofilm formation. An overnight culture of S. epidermidis 
grown in TS was diluted with fresh TS containing 1 % glucose (1:100). Aliquots of 50 μL were transferred to a 
96-well microtiter plate, and 50 μL of 1, dissolved in water at ranging concentrations, was added. After 
overnight incubation at 37 °C, the bacterial suspension was carefully discarded and the wells washed with 
water. The plate was dried and the biofilm fixed by incubation for 1 h at 55 °C before the surface attached 
cells were stained with 100 μL of 0.1 % crystal violet for 5 min. The crystal violet solution was removed and 
the plate once more washed with water and dried at 55 °C for 1 h. After adding 70 μL of 70 % ethanol, the 
plate was incubated at room temperature for 10 min. Biofilm formation was observed by visual inspection of 
the plates. The MIC was defined as the lowest concentration where no biofilm formation was visible. A S. 
epidermidis suspension, diluted with 50 μL of water, was used as a positive control, and 50 μL Staphylococcus 
haemolyticus suspension with 50 μL of water was employed as a negative control. A mixture of 50 μL water 
and 50 μL TS was used as assay control. 
 
Results and Discussion 
 
Biofouling is a complex chemical and biological process, and no single bioassay can be used to accurately 
imitate it. Several different assays and organisms are hence needed to evaluate the AF potential of a 
compound (Briand 2009; Dahms and Hellio 2009). The progression from adsorption of organic molecules to a 
marine surface to the growth of macroepibionts such as macroalgae, crustaceans and mussels also involves 
microorganisms such as bacteria and microalgae. It is therefore unrealistic to assume that a single non-toxic 
AF compound will display activity against all organisms associated with it. In fact, limited access to 
comprehensive screens against all the different stages of the AF process may lead to the discovery of 
promising compounds that are later shown to be inactive in complementary studies against other types of 
foulers (Qian et al. 2010). In the current study of 1, we have included bioassays targeting the main groups of 
marine organisms involved in the different stages of the biofouling process. The well-established AF 
brominated diketopiperazine barettin (3), isolated from G. barretti, was included for comparison and as a 
reference in selected assays.  
 
The initial microfouling of bacteria and microalgae was studied via both adhesion and growth inhibition 
assays. It is generally accepted that the microfouling can facilitate the macrofouling (Beech et al. 2005; Qian et 
al. 2007). Targeting the initial settlement and production of these marine biofilms may thus have beneficial 
effects for limiting the fouling of macroorganisms. The presence of such marine biofilms on surfaces also 
increases the rate of biocorrosion (Beech and Sunner 2004). The growth inhibition was studied via standard 
serial dilution methods against ten relevant marine bacterial strains. Since biofouling is a process associated 
with the adhesion of organisms to a surface, the study of bacterial attachment is highly relevant and that was 
therefore also studied for the same bacterial strains. In addition, eight microalgal strains including the 
diatoms Cylindrotheca closterium and Halamphora coffeaeformis were also studied. Diatoms represent 
particularly relevant strains as they commonly rapidly form resilient slimy layers on marine surfaces (Molino 
and Wetherbee 2008). The data from the microorganism screening is compiled in Table 4. 
 
Table 4  The effect of 1 and 3 on growth and adhesion of fouling marine bacteria and microalgae 
Microorganism  MIC 1 (μg/mL)  MIC 3 (μg/mL) 
 Growth  Adhesion  Growth  Adhesion 
Marine bacteria 
 Halomonas aquamarina  >10  >10  >10  >10 
 Polaribacter irgensii  1  >10  >10  >10 
 Pseudoalteromonas elyakovii  1  >10  >10  >10 
 Roseobacter litoralis  1  >10  >10  >10 
 Shewanella putrefaciens  0.1  >10  10  >10 
 Vibrio aestuarianus  0.1  0.1  0.01  >10 
 Vibrio carchariae  >10  >10  >10  >10 
 Vibrio harveyi  10  >10  >10  >10 
 Vibrio natriegens  >10  0.1  >10  10 
 Vibrio proteolyticus  10  >10  10  >10 
Microalgae 
 Cylindrotheca closterium  >10  >10  0.1  0.1 
 Exanthemachrysis gayraliae  >10  >10  >10  >10 
 Halamphora coffeaeformis  >10  >10  >10  >10 
 Pleurochrysis roscoffensis  10  >10  >10  >10 
 Porphyridium purpureum  >10  >10  0.1  1.0 
 Hymenomonas coronata  1  n.d.1  n.t.2  n.t.2 
 Rhodosorus marinus  1  n.d.1  n.t.2  n.t.2 
 Pleurochrysis carterae  0.1  n.d.1  n.t.2  n.t.2 
1Not determined due to unfavourable growth conditions for the adhesion study 
2Not tested 
 
 
Only concentrations of 1 at or below 10 μg/mL were evaluated for the microorganism studies. This represents 
a threshold for compounds to be regarded as highly active and of further interest from a biotechnological 
viewpoint (Hellio et al. 2009). From Table 4, it is clear that 1 has a pronounced effect on the inhibition of 
marine bacterial growth. All the tested marine bacteria are Gram-negative, and most display MIC values 
below 10 μg/mL, some as low as 0.1 μg/mL. Only the growth of three bacteria (Halomonas aquamarina, Vibrio 
carchariae and Vibrio natriegens) of the tested ten strains tested remained unaffected by 1 at 10 μg/mL, 
illustrating a strong and broad antibacterial activity. In the bacterial adhesion studies, the MIC values were 
higher. Only the two Vibrio species V. natriegens and Vibrio aestuarianus displayed high sensitivity against 1 
with MIC values of 0.1 μg/mL. The high sensitivity of V. natriegens in the adhesion assay is of interest as it 
displayed a MIC >10 μg/mL in the growth assay. V. natriegens is a very rapidly growing sulfate-reducing 
bacterium found on microfouled surfaces (Cheng et al. 2009). Sulfate-reducing bacteria are especially known 
for their role in biocorrosion (Beech and Sunner 2004), and finding a compound inhibiting the adhesion of V. 
natriegens would be highly interesting for reducing the biocorrosion process. The oyster industry has grown 
to be very important for many regions of the world, contributing substantially to social and economic activity 
in the coastal zones. V. aestuarianus is a known pathogen of the commercial pacific oyster Crassostrea gigas 
(Labreuche et al. 2006; De Decker et al. 2011) causing massive mortality outbreaks and a shortage in shellfish. 
Compound 1 inhibited the growth and adhesion of V. aestuarianus at very low concentrations. 
 
In previous studies, 1 has been included in unspecified natural concentrations which are most likely 
significantly higher than those in the current study. This is based on the amounts of similar brominated 
secondary metabolites found and analysed in other tropical sponge extracts which frequently contain such 
compounds (e.g. oroidin, aeroplysinin and sceptrin) in high (0.8-4.9 mg/mL) natural volumetric concentrations 
(Kelly et al. 2003). S. fortis is also rich in 1, and approximately 0.05 % of the organism wet weight is 1, 
indicating that it is an important secondary metabolite. The antibacterial activity of 1 is similar to the 
bromotyrosine derivative zamamistatin isolated from the Okinawan sponge Pseudoceratina purpurea by 
Takada et al. (2001). In comparison to 3, which is both structurally related and a thoroughly studied marine AF 
compound, 1 displays a higher antibacterial activity. Compound 3 previously isolated from G. barrette was 
included in the antimicrobial assay and was active against both Vibrio proteolyticus and Shewanella 
putrefaciens at 10 μg/mL and highly active (MIC=0.01 μg/mL) against V. aestuarianus in analogy to 1. In the 
bacterial adhesion assay, 3 was only active at 10 μg/mL against V. natriegens. No other bacterial strains were 
affected in the concentration range employed. 
 
Microalgae forms slimy layers on marine surfaces that are generally challenging to prevent (Molino and 
Wetherbee 2008), and it was shown that 1 was active against half of the tested microalgal strains. 
Hymenomonas coronata, Rhodosorus marinus and Pleurochrysis carterae were all sensitive to 1 in solution 
with MIC values ranging from 0.1 to 1 μg/mL while Pleurochrysis roscoffensis displayed a MIC value of 10 
μg/mL. The other four strains, including the two diatom species, were unaffected at the tested 
concentrations. In analogy to the bacterial studies, microalgal adhesion was also evaluated. No effect on algal 
adhesion was seen for 1. Growth conditions for the three most sensitive species in the growth assay were 
unfavourable at the time of the adhesion studies, and no data could be obtained for those species. No algal 
toxicity was seen upon extended exposure times. In contrast, 3 was active against both the growth and 
adhesion of the diatom C. closterium at 0.1 μg/mL and Porphyridium purpureum at 0.1 and 1 μg/mL, 
respectively. 
 
The major macrofoulers, barnacles and mussels, were studied via both enzyme and settlement inhibition 
assays. Attachment of bivalves was studied by inhibition studies of phenoloxidase isolated from the byssus 
gland of the common blue mussel, M. edulis. Inhibition of the production of byssus threads by mussels has 
become an established method for evaluating their settlement (Hellio et al. 2000). Other marine invertebrates 
such as barnacle larvae also depend on phenoloxidase for generating a secure surface attachment. The 
function of phenoloxidase is to oxidise both phenylalanine and tyrosine in protein secretions to quinone 
derivatives that crosslink to generate a strong biopolymer enabling the organism to anchor to a surface (Bayer 
et al. 2011). The release of active phenoloxidase is controlled by Ca2+ -dependent signalling pathways, and 
therefore, the intracellular concentration of Ca2+ is thus also an interesting target for the development of AF 
strategies. An inhibitory effect of 1 on phenoloxidase was seen at 1 μg/mL, and the IC50 was determined to 
45.2 μg/mL. Such an IC50 suggests only moderate affinity of 1 for the phenoloxidase despite the α-oxo-oxime 
functionality previously reported to be beneficial for blue mussel phenoloxidase inhibition. The synthetic 5,5’-
dibromohemibastadin-1 (2 in Fig. 1) is a strong phenoloxidase inhibitor with an IC50 value of 0.84 μg/mL (Bayer 
et al. 2011). Compounds 1 and 2 share several structural features such as the dibrominated phenol ring, the 
overall molecular length and the placement of the α-oxo-oxime functionality. The α-oxooxime functionality 
has been shown to be involved with complexation of the two copper(II) ions coordinated by six histidine 
residues in the catalytic centre of the phenoloxidase (Kim and Uyama 2005), and the oxime functionality was 
crucial for the strong inhibition of synthetic bastadin derivatives (Bayer et al. 2011). The main structural 
differences between 2 and 1 lie in the methoxylated phenolic hydroxyl in 1 and the cationic iminoimidazole 
ring. The inhibitory effect of 1 was reduced by nearly 50-fold in comparison to 2, and it is clear that the α-oxo-
oxime functionality is not sufficient for a high affinity interaction with the catalytic site of the enzyme given 
the other structural features of 1. Compound 1 is also positively charged, and charge repulsion within the 
active site of phenoloxidase is a potential explanation for the lower inhibitory activity of 1. The lack of a 
phenolic hydroxyl is also believed to additionally impair the enzyme binding as it represents the natural 
enzyme substrate binding motif (Kim and Uyama 2005). 
 
While phenoloxidase inhibition is a common representative indicator of a compound’s ability to reduce the 
settling abilities for a range of invertebrates (Bayer et al. 2011), studies on B. improvisus larvae were also 
performed to assess the potential effects 1 may specifically have on barnacles. Based on the moderate 
phenoloxidase inhibition, a similar moderate deterring effect on Balanus settlement was anticipated. The 
most commonly studied barnacle in AF studies is Balanus amphitrite which is found in tropical waters. The 
sponge S. fortis (Fig. 2), from which 1 was isolated, is a cold water species which is why we in this study chose 
to target B. improvisus, which is also found in cold water. From a chemical ecology perspective, it has been 
established that when working on marine natural products, it is more judicious to sample organisms and also 
test them primarily on fouling species from the same area (Marechal and Hellio 2011). B. improvisus is 
commonly found in the shallow littoral zone attached to stones, algae or man-made constructions (Barnes 
and Barnes 1962). It is a notorious fouler on smooth artificial substrates such as ship hulls, which has enabled 
its rapid spread amongst continents during the last century. The species has a planktotrophic larval 
development consisting of six naupliar stages and one non-feeding cyprid stage, the latter being responsible 
for finding and attaching to a suitable substratum. The processes of attachment and metamorphosis of the 
cyprid larva into an adult barnacle are collectively referred to as settlement. The cyprids are capable of 
exploring surfaces actively, and the site of settlement is determined using physical and biochemical properties 
of the substratum (Berntsson et al. 2000). The effect of 1 on B. improvisus cyprid larvae is presented below in 
Fig. 3. 
 
Fig. 2 A specimen of S. fortis from which 1 was isolated for the present study. Scale bar represents 2 cm 
 
 
 
 
Fig. 3 Effect of 1 on the settlement of B. improvisus cyprid larvae as presented as percentages of settled (dark 
grey columns) and dead cyprids (light grey columns) and given as means ±SE (n=4). IC50 was determined to 3.0 
μg/mL. 0.1 % DMSO (v/v) in FSW was used as negative control 
 
 
 
 
As evident from the settlement and metamorphosis inhibition data, 1 represents a potent AF compound 
against B. improvisus cyprid larvae. An IC50 of 3.0 μg/mL indicates a high deterring effect and makes 1 
significantly more active against balanide settlement thanmost reported bromotyrosinederived sponge 
metabolites and their synthetic analogues (Ortlepp et al. 2007; Tsukamoto et al. 1996a). Compound 1 is four 
times as active as 2, and no apparent coupling between the moderate phenoloxidase inhibition and Balanus 
settlement is seen for 1, as has been previously reported for the synthetic hemibastadins (Bayer et al. 2011). 
Compound 3 displays an IC50 around 1 μg/mL (Sjogren et al. 2004b) while the structurally related 
dibromopyrrole oroidin (4 in Fig. 1) exhibits an IC50 of 19 μg/mL against the settlement and metamorphosis of 
B. amphitrite cyprids (Tsukamoto et al. 1996b). Compound 1 displays activity similar to Ceratinamide B but is 
one order of magnitude less active than Ceratinamide A, a highly potent AF bromotyrosine derivate with low 
toxicity isolated from the marine sponge P. purpurea (Tsukamoto et al. 1996a). Even at the highest 
concentration tested (20 μg/mL), 1 exhibited low toxicity. Furthermore, an increase in larval time in the water 
column caused by settlement inhibition will inevitably result in higher larval mortality, which may partly 
explain the tendency for a higher cyprid mortality at the highest test concentrations of 1 (Fig. 3). 
 
When the isolation of 1 was initially reported by Litaudon and Guyot in 1986, an activity against S. aureus 
using a disc diffusion assay (15 mm growth inhibition radius using a disc loaded with 50 μg of 1) was included 
(Litaudon and Guyot 1986). Based on that initial data, a screening against human pathogenic bacterial strains 
was also performed to provide a comprehensive overview of the antibacterial effects of 1. Both strains 
resistant to conventional antibiotics and biofilm forming bacteria were included in the test panel of seven 
bacterial strains. Serial dilution experiments were performed to assess the antibacterial activity of 1 against 
human pathogenic bacterial strains, and the data is compiled in Table 5. 
 
Table 5 Antibacterial activity of 1 against human pathogenic bacterial strains 
Bacterial strain  MIC (μg/mL) 
Gram positive 
 Staphylococcus aureus  2.5 
 MRSA  20 
 Staphylococcus epidermidis  50 
 Streptococcus agalactiae  7.5 
 Enterococcus faecalis  22.5 
Gram negative 
 Escherichia coli  7.5 
 Pseudomonas aeruginosa  7.5 
Biofilm inhibition 
 Staphylococcus epidermidis  30 
 
 
The Gram-positive bacteria displayed sensitivities towards 1 ranging from 2.5 to 50 μg/mL while the two 
Gram-negative strains were both highly sensitive with MIC values of 7.5 μg/mL. S. aureus displayed the 
highest sensitivity towards 1 at 2.5 μg/mL, and the methicillin-resistant strain was slightly more tolerant. 
These activities are similar to those reported for synoxazolidinone A which is a closely structurally related 
marine compound isolated from the Arctic ascidian Synoicum pulmonaria (Tadesse et al. 2010). In this 
molecule, the central oxime is replaced with an oxazolidinone core. Previous cytotoxicity studies indicate that 
1 does not act via cellular membrane disruption against mammalian cells (Hanssen et al. 2012). Instead, the 
kill kinetics suggests intracellular targets as no biological effect was seen until cells were incubated with 1 for 
extended periods and at higher concentrations. Even though the antibacterialmode of action of 1 was not 
studied in detail, it appears from the data that the antibacterial effect is primarily induced at the bacterial 
membrane interface. The rapid killing, once a threshold concentration on 
1 has been reached, is typical for a compound acting by a nonspecific membrane depolarisation mechanism 
(Shai 1999) and is exemplified for selected strains in Fig. 4. 
 
Fig. 4 Effects of 1 on selected bacterial strains illustrating the threshold concentrations needed for activity, 
particularly against Gram-positive bacteria 
 
 
 
 
The lipid composition of the bacterial cell membrane differs significantly from the neutral mammalian cell 
membrane (Lohner et al. 2008), and a different mode of action on the anionic bacterial cell membrane is 
suspected. Cationic amphiphilic antimicrobial peptidic derivatives, which 1 can be regarded as, are generally 
active at the bacterial membrane interfaces via several mechanisms (Melo et al. 2009), and a pronounced 
antibacterial effect can be seen even for small diand tripeptidomimetics (Flaten et al. 2011). The inhibition of 
S. epidermidis biofilm formation at 30 μg/mL is seen at a lower concentration than the MIC for growth 
inhibition and may suggest an additional mode of action for 1.  
 
Given the many promising bioactivities of 1 and the relative ease of preparing it, and similar analogues, 
synthetically (Shearman et al. 2010; Ortlepp et al. 2007) it is realistic to assume that libraries of analogues of 1 
is within reach. Compound 1 can be dissected into smaller building blocks allowing for alternative molecular 
assemblies where the key functional groups such as the tyrosine moiety, the central oxime and the cationic 
iminoimidazole can be substituted with analogous chemistries. Several different structural motifs displayed by 
1 can be thus be targeted to generate diverse libraries of compounds that would aid in future structure 
activity relationship studies (SAR) as depicted in Fig. 5. 
 
Fig. 5 Synthetic targets for structure activity relationship studies for establishing the AF pharmacophore of 1 
 
 
 
It is expected that such analogues will be active in several assays and also structurally simplified in comparison 
with one. This is certainly a prerequisite if a large-scale marine use is considered. The structurally related two 
has undergone extensive SAR studies, and those libraries of synthetic analogues have been shown to display 
several medically relevant bioactivities (Richards et al. 2008, 2009) and are being studied further. 
 
The studied extract of S. fortis contains a range of secondary metabolites (unpublished data), but 1 is by far 
the most abundant compound constituting 0.05 % of the organism’s wet weight. This strongly indicates that 1 
serves important ecological functions such as inhibition of the recruitment of potential epibionts and 
competitors, maybe in synergy with other compounds. A tissue specific production or localisation of 1 to 
exposed areas of the organism may further aid to increase the local concentration to levels higher than those 
evaluated in the present study to effectively prevent settlement to generate a broad resistance against 
competing marine species. 
 
Conclusion 
 
Brominated secondary metabolites are common in the marine environment, and the sponge-derived tyrosine 
derivatives are particularly interesting due to their diverse bioactivities and their potential application areas. 
In the present study, 1 was shown to be a powerful micro- and macro-AF compound, mainly against marine 
bacteria and the settlement of barnacles. A lower activity is seen against microalgae, and a moderate 
bioactivity is reported for blue mussel phenoloxidase inhibition. In addition, 1 is active against all tested 
human pathogenic bacterial strains included in the current study, both Gram positive and Gram negative. 
Based on the structural similarities with barettin, oroidin and the synoxazolidinones, it is anticipated that 
ianthelline also exhibits other biological activities yet to be investigated. 
 
 
Acknowledgments  
Marte Albrigtsen is acknowledged for performing the terrestrial bacterial screen, and Robert Andre Johansen 
is acknowledged for providing the photograph of S. fortis. The authors are further grateful to Dr. Lindon 
Moodie (UiT) for linguistic support and to Runar Gjerp Solstad (UiT) for purifying a sample of barettin. The 
study was performed at MabCent which is a centre for research-based innovation at the UiT and supported by 
the Research Council of Norway, Grant no 174885/130. HP and GC were supported by the Centre for Marine 
Chemical Ecology at the University of Gothenburg. 
 
  
References 
Almeida E, Diamantino TC, De Sousa O (2007) Marine paints: the particular case of antifouling paints. Prog Org 
Coat 59:2-20 
 
Barnes H, Barnes M (1962) The distribution and general ecology of Balanus balanoides together with some 
observations on Balanus improvisus in the waters around the coasts of Denmark, southern Sweden and north-
east Germany. Acta Uni Lund 58:1-41 
 
Bayer M, Hellio C, Marechal JP, FrankW, LinWH, Weber H, Proksch P (2011) Antifouling bastadin congeners 
target mussel phenoloxidase and complex copper(ii) ions. Mar Biotechnol 13:1148-1158 
 
Beech WB, Sunner J (2004) Biocorrosion: towards understanding interactions between biofilms and metals. 
Curr Opin Biotechnol 15:181-186 
 
Beech IB, Sunner JA, Hiraoka K (2005) Microbe-surface interactions in biofouling and biocorrosion processes. 
Int Microbiol 8:157-168 
 
Berntsson KM, Jonsson PR, Lejhall M, Gatenholm P (2000) Analysis of behavioural rejection of micro-textured 
surfaces and implications for recruitment by the barnacle Balanus improvisus. J ExpMar Biol 
Ecol 251:59-83 
 
Bhadury P, Wright PC (2004) Exploitation of marine algae: biogenic compounds for potential antifouling 
applications. Planta 219:561-578 
 
Bressy C, Hellio C, Marechal JP, Tanguy B, Margaillan A (2010) Bioassays and field immersion tests: a 
comparison of the antifouling activity of copper-free poly(methacrylic)-based coatings containing tertiary 
amines and ammonium salt groups. Biofouling 26:769-777 
 
Briand JF (2009) Marine antifouling laboratory bioassays: an overview of their diversity. Biofouling 25:297-311 
 
Chambers LD, Stokes KR, Walsh FC, Wood RJK (2006) Modern approaches to marine antifouling coatings. Surf 
Coat Technol 201: 3642-3652 
 
Chambers LD, Hellio C, Stokes KR, Dennington SP, Goodes LR, Wood RJK, Walsh FC (2011) Investigation of 
Chondrus crispus as a potential source of new antifouling agents. Int Biodeterior Biodegrad 65:939-946 
 
Cheng S, Tian JT, Chen SG, Lei YH, Chang XT, Liu T, Yin YS (2009) Microbially influenced corrosion of stainless 
steel by marine bacterium Vibrio natriegens: (i) corrosion behavior. Math Sci Eng C-Biol 29:751-755 
 
Ciminiello P, Fattorusso E, Magno S, Pansini M (1995) Chemistry of Verongida sponges. 4. Comparison of the 
secondary metabolite composition of several specimens of Pseudoceratina crassa. J Nat Prod 58:689-696 
 
Dahms HU, Hellio C (2009) Laboratory bio-assays for screening marine antifouling compounds. In: Hellio C, 
Yebra DM (eds) Advances in marine antifouling coatings and technologies. Woodhead Publishing, New York 
 
De Decker S, Normand J, Saulnier D, Pernet F, Castagnet S, Boudry P (2011) Responses of diploid and triploid 
pacific oysters Crassostrea gigas to vibrio infection in relation to their reproductive status. J Invertebr Pathol 
106:179-191 
 
De Nys R, Steinberg PD (2002) Linking marine biology and biotechnology. Curr Opin Biotechnol 13:244-248 
Dobretsov S, Dahms HU, Qian PY (2006) Inhibition of biofouling by marine microorganisms and their 
metabolites. Biofouling 22:43-54 
 
Ellis DV, Pattisina LA (1990) Widespread neogastropod imposex - a biological indicator of global TBT 
contamination. Mar Pollut Bull 21:248-253 
 
Fitridge I, Dempster T, Guenther J, De Nys R (2012) The impact and control of biofouling inmarine 
aquaculture: a review. Biofouling 28: 649-669 
 
Flaten GE, Kottra G, Stensen W, Isaksen G, Karstad R, Svendsen JS, Daniel H, Svenson J (2011) In vitro 
characterization of human peptide transporter hPEPT1 interactions and passive permeation studies of short 
cationic antimicrobial peptides. J Med Chem 54: 2422-2432 
 
Fusetani N (2004) Biofouling and antifouling. Nat Prod Rep 21:94-104 
 
Fusetani N (2011) Antifouling marine natural products. Nat Prod Rep 28: 400-410 
 
GerwickWH, Fenner AM (2013) Drug discovery from marine microbes. Microb Ecol 65:800-806 
 
Gerwick WH, Moore BS (2012) Lessons from the past and charting the future of marine natural products drug 
discovery and chemical biology. Chem Biol 19:85-98 
 
Hanssen KO, Andersen JH, Stiberg T, Engh RA, Svenson J, Geneviere AM, Hansen E (2012) Antitumoral and 
mechanistic studies of ianthelline isolated from the arctic sponge Stryphnus fortis. Anticancer Res 32:4287-
4297 
 
Hellio C, Bourgougnon N, Le Gal Y (2000) Phenoloxidase (ec 1.14.18.1) from the byssus gland of Mytilus edulis: 
purification, partial characterization and application for screening products with potential antifouling 
activities. Biofouling 16:235-244 
 
Hellio C, Tsoukatou M, Marechal JP, Aldred N, Beaupoil C, Clare AS, Vagias C, Roussis V (2005) Inhibitory 
effects of Mediterranean sponge extracts and metabolites on larval settlement of the barnacle Balanus 
amphitrite. Mar Biotechnol 7:297-305 
 
Hellio C, Marechal JP, DaGama BP, Pereira RC, Clare AS (2009) Natural marine products with antifouling 
activities. In: Hellio C, Yebra DM (eds) Advances in marine antifouling coatings and technologies. Woodhead 
Publishing, New York  
 
Jellali R, Campistron I, Pasetto P, Laguerre A, Gohier F, Hellio C, Pilard JF, Mouget JL (2013) Antifouling activity 
of novel polyisoprenebased coatings made from photocurable natural rubber derived oligomers. Prog Org 
Coat 76:1203-1214 
 
Kelly SR, Jensen PR, Henkel TP, Fenical W, Pawlik JR (2003) Effects of Caribbean sponge extracts on bacterial 
attachment. Aquat Microb Ecol 31:175-182 
 
Kelly SR, Garo E, Jensen PR, Fenical W, Pawlik JR (2005) Effects of Caribbean sponge secondary metabolites on 
bacterial surface colonization. Aquat Microb Ecol 40:191-203 
 
Kim YJ, Uyama H (2005) Tyrosinase inhibitors from natural and synthetic sources: structure, inhibition 
mechanism and perspective for the future. Cell Mol Life Sci 62:1707-1723 
 
Kotake Y (2012) Molecular mechanisms of environmental organotin toxicity in mammals. Biol Pharm Bull 
35:1876-1880  
 
Labreuche Y, Lambert C, Soudant P, Boulo V, Huvet A, Nicolas JL (2006) Cellular and molecular hemocyte 
responses of the pacific oyster, Crassostrea gigas, following bacterial infection with Vibrio aestuarianus strain 
01/32. Microbes Infect 8:2715-2724 
 
Lidgren G, Bohlin L (1986) Studies of Swedish marine organisms. 7. A novel biologically-active indole alkaloid 
from the sponge Geodia baretti. Tetrahedron Lett 27:3283-3284 
 
Litaudon M, Guyot M (1986) Ianthelline, a new derivative of 3,5-dibromo-tyrosine isolated from the sponge 
Ianthella-ardis from the Bahamas. Tetrahedron Lett 27:4455-4456 
 
Lohner K, Sevcsik E, Pabst G (2008) Liposome-based biomembrane mimetic systems: implications for lipid-
peptide interactions. In: Liu AL (ed) Advances in planar lipid bilayers and liposomes. Elsevier, Amsterdam 
 
Marechal JP, Hellio C (2009) Challenges for the development of new non-toxic antifouling solutions. Int J Mol 
Sci 10:4623-4637  
 
Marechal JP, Hellio C (2011) Antifouling activity against barnacle cypris larvae: do target species matter 
(Amphibalanus amphitrite versus Semibalanus balanoides)? Int Biodeterior Biodegrad 65:92-101 
 
Melander C, Moeller PDR, Ballard TE, Richards JJ, Huigens RW, Cavanagh J (2009) Evaluation of dihydrooroidin 
as an antifouling additive in marine paint. Int Biodeterior Biodegrad 63:529-532 
 
Melo MN, Ferre R, Castanho M (2009) Opinion antimicrobial peptides: linking partition, activity and high 
membrane-bound concentrations. Nat Rev Microbiol 7:245-250 
 
Molino PJ, Wetherbee R (2008) The biology of biofouling diatoms and their role in the development of 
microbial slimes. Biofouling 24: 365-379 
 
Muller WEG, Wang XH, Proksch P, Perry CC, Osinga R, Garderes J, Schroder HC (2013) Principles of biofouling 
protection in marine sponges: a model for the design of novel biomimetic and bioinspired coatings in the 
marine environment? Mar Biotechnol 15: 375-398 
 
Nakanishi T (2008) Endocrine disruption induced by organotin compounds; organotins function as a powerful 
agonist for nuclear receptors rather than an aromatase inhibitor. J Toxicol Sci 33:269-276 
 
Okoro HK, Fatoki OS, Adekola FA, Ximba BJ, Snyman RG (2011) Sources, environmental levels and toxicity of 
organotin in marine environment-a review. Asian J Chem 23:473-482 
 
Ortlepp S, SjogrenM, DahlstromM,Weber H, Ebel R, Edrada R, Thoms C, Schupp P, Bohlin L, Proksch P (2007) 
Antifouling activity of bromotyrosine-derived sponge metabolites and synthetic analogues. 
Mar Biotechnol 9:776-785 
 Qian PY, Lau SCK, Dahms HU, Dobretsov S, Harder T (2007) Marine biofilms as mediators of colonization by 
marine macroorganisms: implications for antifouling and aquaculture. Mar Biotechnol 9:399-410 
 
Qian PY, Xu Y, Fusetani N (2010) Natural products as antifouling compounds: recent progress and future 
perspectives. Biofouling 26:223-234 
 
Richards JJ, Ballard TE, Huigens RW, Melander C (2008) Synthesis and screening of an oroidin library against 
Pseudomonas aeruginosa biofilms. Chembiochem 9:1267-1279 
 
Richards JJ, Reyes S, Stowe SD, Tucker AT, Ballard TE, Mathies LD, Cavanagh J, Melander C (2009) Amide 
isosteres of oroidin: assessment of antibiofilm activity and C. elegans toxicity. J Med Chem 52:4582-4585 
 
Santos Acevedo M, Puentes C, Carreno K, Gomez Leon J, Stupak M, Garcia M, Perez M, Blustein G (2013) 
Antifouling paints based on marine natural products from Colombian Caribbean. Int Biodeterior Biodegrad 
83:97-104 
 
Shai Y (1999) Mechanism of the binding, insertion and destabilization of phospholipid bilayer membranes by 
alpha-helical antimicrobial and cell non-selective membrane-lytic peptides. BBA-Biomembr 1462: 
55-70 
 
Shearman JW, Myers RM, Beale TM, Brenton JD, Ley SV (2010) Total syntheses of the bromotyrosine-derived 
natural products ianthelline, 5-bromoverongamine and jbir-44. Tetrahedron Lett 51:4812-4814 
 
Sipkema D, Franssen MCR, Osinga R, Tramper J, Wijffels RH (2005) Marine sponges as pharmacy. Mar 
Biotechnol 7:142-162 
 
Sjogren M, Dahlstrom M, Goransson U, Jonsson PR, Bohlin L (2004a) Recruitment in the field of Balanus 
improvisus and Mytilus edulis in response to the antifouling cyclopeptides barettin and 8,9-dihydrobarettin 
from the marine sponge Geodia barretti. Biofouling 20:291-297 
 
Sjogren M, Goransson U, Johnson AL, Dahlstrom M, Andersson R, Bergman J, Jonsson PR, Bohlin L (2004b) 
Antifouling activity of brominated cyclopeptides from the marine sponge Geodia barretti. J Nat Prod 67:368-
372 
 
Solter S, Dieckmann R, Blumenberg M, Francke W (2002) Barettin, revisited? Tetrahedron Lett 43:3385-3386  
 
Sonak S, Bhosle NB (1995) A simple method to assess bacterial attachment to surfaces. Biofouling 9:31-38 
 
Stowe SD, Richards JJ, Tucker AT, Thompson R, Melander C, Cavanagh J (2011) Anti-biofilm compounds 
derived from marine sponges. Mar Drugs 9:2010-2035 
 
Svenson J (2013) MabCent: Arctic marine bioprospecting in Norway. Phytochem Rev 12:567-578 
 
Tadesse M, Gulliksen B, Strom MB, Styrvold OB, Haug T (2008) Screening for antibacterial and antifungal 
activities in marine benthic invertebrates from northern Norway. J Invertebr Pathol 99:286-293 
 
Tadesse M, Strom MB, Svenson J, Jaspars M, Milne BF, Torfoss V, Andersen JH, Hansen E, Stensvag K, Haug T 
(2010) Synoxazolidinones a and b: novel bioactive alkaloids from the ascidian Synoicum pulmonaria. Org Lett 
12:4752-4755 
 
Takada N, Watanabe R, Suenaga K, Yamada K, Ueda K, Kita M, Uemura D (2001) Zamamistatin, a significant 
antibacterial bromotyrosine derivative, from the Okinawan sponge Pseudoceratina purpurea. Tetrahedron 
Lett 42:5265-5267 
 
Thabard M, Gros O, Hellio C, Marechal JP (2011) Sargassum polyceratium (phaeophyceae, fucaceae) surface 
molecule activity towards fouling organisms and embryonic development of benthic species. Bot Mar 54:147-
157 
 
Tsukamoto S, Kato H, Hirota H, Fusetani N (1996a) Ceratinamides a and b: new antifouling dibromotyrosine 
derivatives from the marine sponge Pseudoceratina purpurea. Tetrahedron 52:8181-8186 
 
Tsukamoto S, Kato H, Hirota H, Fusetani N (1996b) Mauritiamine, a new antifouling oroidin dimer from the 
marine sponge Agelas mauritiana. J Nat Prod 59:501-503 
 
Yamada A, Kitamura H, Yamaguchi K, Fukuzawa S, Kamijima C, Yazawa K, Kuramoto M, Wang GYS, Fujitani Y, 
Uemura D (1997) Development of chemical substances regulating biofilm formation. B Chem Soc Jpn 70:3061-
3069 
 
Yebra DM, Kiil S, Dam-Johansen K (2004) Antifouling technology - past, present and future steps towards 
efficient and environmentally friendly antifouling coatings. Prog Org Coat 50:75-104 
 
